Public subsidies and the recommendation of child vaccines among primary care physicians: a nationwide cross-sectional study in Japan

BMJ Open
Yuta SakanishiShunichi Fukuhara

Abstract

Although public subsidies and physician recommendations for vaccination play key roles in increasing childhood vaccination coverage, the association between them remains uncertain. This study aimed to identify the association between awareness of public subsidies and recommendations for Haemophilus influenzae type b (Hib), Streptococcus pneumoniae (pneumococcal conjugate vaccine (PCV)) and human papillomavirus (HPV) vaccinations among primary care physicians in Japan. This is a cross-sectional study. In 2012, a questionnaire was distributed among 3000 randomly selected physicians who were members of the Japan Primary Care Association. From the questionnaire, participants were limited to physicians who administered childhood vaccinations. The primary measures were participants' awareness of public subsidies and their recommendation levels for Hib, PCV and HPV vaccines. Multiple logistic regression analysis was performed to investigate the association between awareness and recommendation, with adjustment for possible confounders. The response rate was 25.8% (743/2880). Of 743 physician respondents, 434 were included as analysis subjects. The proportions of those who recommended vaccinations were 57.1% for Hib, 54.1% for PCV and 5...Continue Reading

References

Dec 1, 1986·American Journal of Diseases of Children·S L CochiW A Orenstein
Nov 1, 1995·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·M SaarinenJ Eskola
Mar 5, 2002·Journal of Public Health Medicine·T Doran, R McCann
Apr 2, 2002·MMWR. Morbidity and Mortality Weekly Report·UNKNOWN Centers for Disease Control and Prevention (CDC)
Jul 31, 2003·Journal of Paediatrics and Child Health·J T MilledgeS Woolfenden
Dec 4, 2003·The Journal of the American Board of Family Practice·Matthew M DavisSarah J Clark
Feb 15, 2005·The Journal of the American Board of Family Practice·Natalia Vukshich OsterKelly Howell
Jul 14, 2007·Preventive Medicine·Noel T Brewer, Karah I Fazekas
Jul 1, 2008·The American Journal of Medicine·David R JohnsonKim Lipczynski
Feb 4, 2010·Women's Health Issues : Official Publication of the Jacobs Institute of Women's Health·Jessica L BarnackCarolyne Swain
Nov 10, 2010·Annals of Family Medicine·Doug Campos-OutcaltHerbert F Young
Jan 11, 2011·Vaccine·Gary L FreedMargaret S Coleman
Jun 5, 2013·Human Vaccines & Immunotherapeutics·Sachiko Ozawa, Meghan L Stack
Dec 21, 2013·American Journal of Preventive Medicine·Susan T VadaparampilAnna R Giuliano
Jan 21, 2014·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·P KramarzL Pastore Celentano
Jun 25, 2014·Emerging Infectious Diseases·Naoko ChibaUNKNOWN Invasive Pneumococcal Diseases Surveillance Study Group
Dec 23, 2014·Vaccine·Aiko Shono, Masahide Kondo
Jul 1, 2015·Lancet·Sharon J B HanleyReiko Kishi
Nov 10, 2015·Kansenshōgaku zasshi. The Journal of the Japanese Association for Infectious Diseases·Ayako SaitoNobuaki Takeyasu
Nov 13, 2015·MMWR. Morbidity and Mortality Weekly Report·Saleena SubaiyaLaura Conklin
Sep 25, 2016·The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine·Jai K DasZulfiqar A Bhutta
Mar 9, 2017·Human Vaccines & Immunotherapeutics·Asami YagiKentaro Shimura

❮ Previous
Next ❯

Citations

Mar 1, 2019·FEMS Microbiology Ecology·Nobuhiko ShigyoToshihide Hirao
Oct 19, 2019·Community Dentistry and Oral Epidemiology·Ruth FreemanVanessa Muirhead

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.